Trupanion (NASDAQ:TRUP – Get Free Report) and NeueHealth (NYSE:NEUE – Get Free Report) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.
Earnings and Valuation
This table compares Trupanion and NeueHealth’s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Trupanion | $1.11 billion | 0.81 | -$44.69 million | ($1.08) | -19.78 |
| NeueHealth | $1.16 billion | 0.04 | -$1.15 billion | ($151.20) | -0.04 |
Trupanion has higher earnings, but lower revenue than NeueHealth. Trupanion is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Analyst Recommendations
This is a summary of recent ratings and price targets for Trupanion and NeueHealth, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Trupanion | 0 | 3 | 1 | 0 | 2.25 |
| NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
Trupanion currently has a consensus price target of $33.20, indicating a potential upside of 55.43%. NeueHealth has a consensus price target of $8.00, indicating a potential upside of 26.78%. Given Trupanion’s stronger consensus rating and higher probable upside, research analysts clearly believe Trupanion is more favorable than NeueHealth.
Insider & Institutional Ownership
63.9% of NeueHealth shares are owned by institutional investors. 5.8% of Trupanion shares are owned by company insiders. Comparatively, 64.3% of NeueHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Trupanion and NeueHealth’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Trupanion | -4.03% | -15.19% | -5.95% |
| NeueHealth | -71.23% | N/A | -1.21% |
Summary
Trupanion beats NeueHealth on 8 of the 14 factors compared between the two stocks.
About Trupanion
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
About NeueHealth
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
